Publicaciones científicas

medRxiv [Preprint]. 2022 Sep 26:2022.09.22.22280245.doi: 10.1101/2022.09.22.22280245.

Infliximab for Treatment of Adults Hospitalized with Moderate or Severe Covid-19

Lancet Infect Dis. 2016 Apr;16(4):421-30.doi: 10.1016/S1473-3099(16)00017-7. Epub 2016 Feb 5.

Efficacy and safety of oral solithromycin versus oral moxifloxacin for treatment of community-acquired bacterial pneumonia: a global, double-blind, multicentre, randomised, active-controlled, non-inferiority trial (SOLITAIRE-ORAL)